Company Overview

PRIME exits and American HealthCare Capital are pleased to exclusively represent a Medicare certified hospice for sale in Southern Texas. Founded in 2020, this CHAP-accredited hospice is dedicated to delivering compassionate, patient-centered end-of-life care. The experienced team has successfully grown the company to serve nearly 30 patients, with a focus on serving the counties of Hidalgo, Starr, Cameron, and Willacy.

Payers and Census

The company is currently in the process of getting approved to accept Medicaid. They expect to have final authorization in Summer 2025. Currently, their payer mix is 100% Medicare.The current census hovers around 27 patients with an average length of stay is 25 days. They have had no issues with CAP, and the company has no outstanding liabilities.

Financial Overview

The hospice has grown exponentially over the past few years. Gross revenues were almost $120,000 in 2022 and increased to over $486,000 in 2023. They achieved nearly $1.4 million in 2024 with an adjusted EBITDA of $446,328 (32%), and they expect to gross $1.5 million or more in 2025 with a similar EBITDA margin.

Staff and Exit Plan

There is a full complement of staff that is expected to stay on under new ownership. The owner would like to retire but will assist during a transition period as needed.

Asking Price

The asking price for this opportunity is $1.7 million, which excludes cash, receivables, and working capital.